Literature DB >> 6589006

Effect of nicotine replacement on the cigarette withdrawal syndrome.

R J West, M J Jarvis, M A Russell, M E Carruthers, C Feyerabend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6589006     DOI： 10.1111/j.1360-0443.1984.tb00265.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN： 0952-0481


× No keyword cloud information.
  45 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

3.  Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal.

Authors:  Robert West; Peter Hajek
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

Review 4.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

5.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

6.  Effects of cigarette smoking and abstinence on Stroop task performance.

Authors:  Catherine P Domier; John R Monterosso; Arthur L Brody; Sara L Simon; Adrianna Mendrek; Richard Olmstead; Murray E Jarvik; Mark S Cohen; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2007-07-19       Impact factor: 4.530

7.  Signs and symptoms from nicotine gum abstinence.

Authors:  D K Hatsukami; K Skoog; M Huber; J Hughes
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 8.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.

Authors:  S J Leischow; D P Sachs; M D Hansen; A G Bostrom
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Urinary adrenaline concentrations during 10 days of smoking abstinence.

Authors:  R J West; M A Russell; M J Jarvis; T Pizzey; B Kadam
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.